Connect with us

Headlines

Outdoor Eyewear Company Names US CEO

The firm is based in France.

mm

Published

on

WILLISTON, VT — Julbo Eyewear, a French eyewear brand based in the Jura Mountains, has named David Crothers as CEO of its U.S. operations.

Crothers has been marketing manager at Julbo, which focuses on outdoor eyewear, since 2015, growing the brand’s visibility within the ski and bike categories.

In 2008, Crothers started the climbing website Climberism, which was eventually absorbed by Height of Land Publications. Crothers managed Height of Land’s digital assets and eventually was promoted to photo editor for all Height of Land publications, before moving into the marketing role at Julbo.

“I’ve got some big shoes to fill. Nick has been the face of the brand for a long time,” Crothers says. “I’m extremely excited for the opportunity. Julbo is a terrific brand and we have a great team.”

Julbo will continue building on its core mountain and outdoor heritage while focusing on growing its ski, bike and lifestyle categories, according to a press release.

“We strongly believe that with Dave’s experience, combined with the full support of France, we will continue to build our presence in the U.S. market,” said Pierre Burgelin, international sales director for the company.

Advertisement

Advertisement

SPONSORED VIDEO

SPONSORED BY WALMAN OPTICAL

Don’t Lose Patients to Online

In this compelling video, Dr. Mile Brujic of Premier Vision Group discusses all the ways that your practice beats the online competition—hands down! The formula for success? Don’t sell yourself short and acknowledge all the benefits that you, as a provider, give to your patients.

Promoted Headlines

Want more INVISION? Subscribe to our newsletter.

Comment

Headlines

Smoking May Cause Loss of Color Vision, Study Suggests

The findings indicated significant changes in red-green and blue-yellow color vision.

mm

Published

on

Smoking more than 20 cigarettes a day can damage your vision, researchers have found.

The study included 71 healthy people who smoked fewer than 15 cigarettes in their lives and 63 who smoked more than 20 cigarettes a day, were diagnosed with tobacco addiction and reported no attempts to stop smoking. The participants were between the ages of 25 and 45 and had normal or corrected-to-normal vision as measured by standard visual acuity charts, according to a Rutgers press release.

Podcast: More Ways to Motivate Your Own Eyecare Business Team
INVISION Podcast

Podcast: More Ways to Motivate Your Own Eyecare Business Team

Podcast: Why Can’t We All Just Get Along?
INVISION Podcast

Podcast: Why Can’t We All Just Get Along?

Podcast: Try Not to Blink Talks About the Business of Cannabis, and Its Role in Modern Healthcare
Try Not to Blink

Podcast: Try Not to Blink Talks About the Business of Cannabis, and Its Role in Modern Healthcare

The researchers looked at how participants discriminated contrast levels (subtle differences in shading) and colors while seated 59 inches from a 19-inch cathode-ray tube monitor that displayed stimuli while researchers monitored both eyes simultaneously.

The findings indicated significant changes in the smokers’ red-green and blue-yellow color vision, which suggests that consuming substances with neurotoxic chemicals, such as those in cigarettes, may cause overall color vision loss. They also found that the heavy smokers had a reduced ability to discriminate contrasts and colors when compared to the non-smokers.

“Cigarette smoke consists of numerous compounds that are harmful to health, and it has been linked to a reduction in the thickness of layers in the brain, and to brain lesions, involving areas such as the frontal lobe, which plays a role in voluntary movement and control of thinking, and a decrease in activity in the area of the brain that processes vision,” said co-author Steven Silverstein, director of research at Rutgers University Behavioral Health Care.

“Previous studies have pointed to long-term smoking as doubling the risk for age-related macular degeneration and as a factor causing lens yellowing and inflammation. Our results indicate that excessive use of cigarettes, or chronic exposure to their compounds, affects visual discrimination, supporting the existence of overall deficits in visual processing with tobacco addiction.”

The research appears in the journal Psychiatry Research.

Although the research did not give a physiological explanation for the results, Silverstein said that since nicotine and smoking harm the vascular system, the study suggests they also damage blood vessels and neurons in the retina.

The Centers for Disease Control and Prevention estimates that 34.3 million adults in the U.S. currently smoke cigarettes and that more than 16 million live with a smoking-related disease, many of which affect the cardiovascular system.

Silverstein said the findings also suggest that research into visual processing impairments in other groups of people, such as those with schizophrenia who often smoke heavily, should take into account their smoking rate or independently examine smokers versus non-smokers.

The study was made available online in November 2018 ahead of final publication in print in January 2019

The study was conducted by researchers from the Perception, Neuroscience and Behavior Laboratory in Brazil with Silverstein as a consultant.

Continue Reading

Headlines

Blue Light Filters Disappoint in New Study

They didn’t reduce the symptoms of digital eyestrain.

mm

Published

on

A new study suggests that blue light filters aren’t particularly useful in quelling the symptoms of digital eyestrain.

Researchers compared the effectiveness of blue-blocking filters and equiluminant neutral density filters, Healio reports. They published their study in the journal in Optometry and Vision Science.

Podcast: More Ways to Motivate Your Own Eyecare Business Team
INVISION Podcast

Podcast: More Ways to Motivate Your Own Eyecare Business Team

Podcast: Why Can’t We All Just Get Along?
INVISION Podcast

Podcast: Why Can’t We All Just Get Along?

Podcast: Try Not to Blink Talks About the Business of Cannabis, and Its Role in Modern Healthcare
Try Not to Blink

Podcast: Try Not to Blink Talks About the Business of Cannabis, and Its Role in Modern Healthcare

They found no difference in the effectiveness of the two at reducing symptoms of digital eyestrain.

“These results do not support the use of blue-blocking filters for the treatment of digital eyestrain,” study co-author Mark Rosenfield was quoted saying.

Advertisement

Healio reports that blue-blocking filters “were not shown to reduce any apparent symptoms” of digital eyestrain.

Rosenfield acknowledged that there is “no physiological mechanism at the present time that links blue light with eyestrain.” But he said blue light may interfere with circadian rhythms and disrupt the ability to fall asleep.

Read more at Healio

Continue Reading

Headlines

Meditation Might Help Treat a Common Eye Disease, Study Suggests

It could serve as an adjunct to medications.

mm

Published

on

Meditation may be helpful in treating glaucoma, a new study suggests.

The research found that a short course of mindfulness-based stress reduction by meditation reduced intraocular pressure, normalized stress biomarkers and positively modified gene expression in patients with primary-open angle glaucoma, the American Optometric Association reports.

Podcast: More Ways to Motivate Your Own Eyecare Business Team
INVISION Podcast

Podcast: More Ways to Motivate Your Own Eyecare Business Team

Podcast: Why Can’t We All Just Get Along?
INVISION Podcast

Podcast: Why Can’t We All Just Get Along?

Podcast: Try Not to Blink Talks About the Business of Cannabis, and Its Role in Modern Healthcare
Try Not to Blink

Podcast: Try Not to Blink Talks About the Business of Cannabis, and Its Role in Modern Healthcare

The research was published in the Journal of Glaucoma. It suggests a possible role for meditation as an adjunctive clinical therapy.

The findings “provide tantalizing insight about a therapeutic option that may accompany tried-and-true pharmaceuticals, as well as hint at the role stress may play in glaucoma,” according to AOA.

Researchers “hope this latest study can validate another option for helping prevent irreversible optic nerve head damage.”

Advertisement

For the study, researchers enrolled 90 primary-open angle glaucoma patients and directed a study group to 21 days of daily, hour-long mindfulness meditation under the supervision of a certified meditation teacher.

The researchers said future studies should address how long the changes last and whether mindfulness meditation helps visual field function over time.

Read more at the AOA

Continue Reading

Advertisement

Advertisement

Advertisement

Most Popular